Go back

Clan swept aside by Div. I opponents

Sports
EIC
EIC
2 min.
0
896

Gonzaga University entered this year’s NCAA March Madness Tournament as a No. 1 seed, featuring the 13th-overall draft pick in the 2013 NBA draft, Kelly Olynyk, as well as the son of NBA Hall-of-Famer John Stockton.

The Bulldogs are an elite, Division I organization. And the Clan visited them last week.

It was the first exhibition game of the men’s basketball team’s new season, and it started off how you’d expect: Gonzaga roared out to a 15–3 lead, and held the Clan to 1-of-17 shooting to start the game. Another three-pointer from SFU’s senior guard Dillon Hamilton would bring the lead to 15–6; the nine-point differential would be the Clan’s smallest deficit of the game.

At the half, the Bulldogs had nearly doubled the SFU’s scoring output, sporting a 52–28 lead. The Clan refused to roll over though.

SFU’s David Gebru named a Great Northwest Athletic Conference (GNAC) preseason all-star, finished with 14 points to lead the Clan, and two newcomers, Justin Cole and Sango Niang, also hit double digits in points. And though the final score wasn’t close, it was closer than you may have expected, with SFU dropping the contest 103–68.

“This game was an unbelievable experience for our team,” said SFU head coach James Blake. “Our guards played tough defence and really challenged their perimeter players. They are just so big and we really struggled on the boards.”

“I wanted to play the hardest teams in our preseason schedule and we are. These games will prepare us for an unbelievably tough GNAC schedule,” he added.

His team played another one of “those games” last Saturday, against another Division I opponent, the University of Montana Grizzlies, who won the Big Sky Conference championship last year.

The game started off similarly to the game against Gonzaga: the Clan fell behind 10–0 before getting their first points. Unlike the Bulldogs, the Grizzlies defence completely stifled the Clan attack, and Montana had a commanding 46–19 lead at the half, a deficit that would only increase in a 102–49 loss.

“We came out flat against the defending Big Sky champion,” said Blake after the game. “Montana took us out of our offence early and we never got into a good flow . . .”

“Unfortunately we just ran out of steam playing against good Division I teams back-to-back.”

The good news is, the competition won’t get any tougher for SFU. There were no expectations on the Clan to win these two games, instead it was more of an opportunity to see how some of the best college basketball teams in the world operate.

The Clan are far from that recognition, but have a shot this year to bounce back and be one of the best teams in their conference. And after playing two Div. I schools, it’s only going to get easier.

Was this article helpful?
0
0

Leave a Reply

Block title

New immunotherapy treatment provides hope for aggressive cancer

News Peak Web -
By: Lucaiah Smith-Miodownik, News Writer Surgery, chemotherapy, and radiation therapy are often recognized as the three most common forms of cancer treatment. Sometimes, the latter two approaches become no longer effective when cancers become drug resistant, allowing the cells to further spread. At the University of Calgary, however, promising developments in immunotherapy intervention seek to provide alternative treatment when common therapies are not viable.  Cells continually divide to replenish dying cells, but certain gene mutations can create cancer cells, which divide and spread in an uncontrolled manner. The human body naturally defends itself from cancerous cells, though sometimes they can “hide from the immune system and avoid being destroyed,” according to the Canadian Cancer Society. Immunotherapy seeks to help strengthen the ability to recognize and fight...

Read Next

Block title

New immunotherapy treatment provides hope for aggressive cancer

News Peak Web -
By: Lucaiah Smith-Miodownik, News Writer Surgery, chemotherapy, and radiation therapy are often recognized as the three most common forms of cancer treatment. Sometimes, the latter two approaches become no longer effective when cancers become drug resistant, allowing the cells to further spread. At the University of Calgary, however, promising developments in immunotherapy intervention seek to provide alternative treatment when common therapies are not viable.  Cells continually divide to replenish dying cells, but certain gene mutations can create cancer cells, which divide and spread in an uncontrolled manner. The human body naturally defends itself from cancerous cells, though sometimes they can “hide from the immune system and avoid being destroyed,” according to the Canadian Cancer Society. Immunotherapy seeks to help strengthen the ability to recognize and fight...

Block title

New immunotherapy treatment provides hope for aggressive cancer

News Peak Web -
By: Lucaiah Smith-Miodownik, News Writer Surgery, chemotherapy, and radiation therapy are often recognized as the three most common forms of cancer treatment. Sometimes, the latter two approaches become no longer effective when cancers become drug resistant, allowing the cells to further spread. At the University of Calgary, however, promising developments in immunotherapy intervention seek to provide alternative treatment when common therapies are not viable.  Cells continually divide to replenish dying cells, but certain gene mutations can create cancer cells, which divide and spread in an uncontrolled manner. The human body naturally defends itself from cancerous cells, though sometimes they can “hide from the immune system and avoid being destroyed,” according to the Canadian Cancer Society. Immunotherapy seeks to help strengthen the ability to recognize and fight...

Simon Fraser University’s independent student newspaper since 1965.

For advertising inquiries: [email protected]
For promotional inquiries: [email protected]

© The Peak Publications Society

Simon Fraser University’s independent student newspaper since 1965.

For advertising inquiries: [email protected]
For promotional inquiries: [email protected]

© The Peak Publications Society